Ziad Hijazi Selected Research

Warfarin (Coumadin)

3/2024	Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial.
1/2023	Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation.
1/2023	Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF.
1/2022	Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
1/2021	Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Left Ventricular Hypertrophy: Insights From the ARISTOTLE Trial.
1/2020	Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease.
1/2020	Regional variation in clinical characteristics and outcomes in patients with atrial fibrillation: Findings from the ARISTOTLE trial.
1/2020	Cardiovascular outcomes, bleeding risk, and achieved blood pressure in patients on long-term anticoagulation with the thrombin antagonist dabigatran or warfarin: data from the RE-LY trial.
7/2019	International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin.
1/2019	Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ziad Hijazi Research Topics

Disease

64	Atrial Fibrillation 03/2024 - 04/2012
44	Stroke (Strokes) 03/2024 - 04/2012
32	Hemorrhage 01/2023 - 11/2012
18	Embolism (Embolus) 01/2023 - 11/2012
9	Ischemic Stroke 03/2024 - 12/2015
9	Inflammation (Inflammations) 01/2023 - 11/2014
8	Myocardial Infarction 01/2023 - 02/2015
7	Heart Failure 01/2023 - 01/2014
4	Chronic Renal Insufficiency 01/2020 - 11/2012
3	Transient Ischemic Attack 10/2023 - 01/2014
3	Acute Coronary Syndrome 01/2021 - 11/2014
3	Death (Near-Death Experience) 02/2015 - 06/2013
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 01/2020
2	Vascular Calcification 11/2021 - 12/2020
2	Thrombosis (Thrombus) 01/2021 - 01/2020
2	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2021 - 01/2019
2	Fibrosis (Cirrhosis) 12/2020 - 01/2017
2	Body Weight (Weight, Body) 01/2019 - 01/2016
1	Thromboembolism 10/2023
1	Cerebral Hemorrhage 10/2022
1	Necrosis 01/2022
1	Atherosclerotic Plaque (Atheroma) 01/2021
1	Carcinogenesis 12/2020
1	Ischemia 12/2020
1	Infections 11/2020
1	COVID-19 11/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2020
1	Frailty 01/2019
1	Sudden Death 10/2018
1	Obesity 01/2018
1	Dyslipidemias (Dyslipidemia) 01/2018
1	Clinical Deterioration 01/2016
1	Pulmonary Embolism 12/2015
1	Vascular Diseases (Vascular Disease) 01/2014
1	Diabetes Mellitus 01/2014
1	Hypertension (High Blood Pressure) 01/2014
1	Heart Diseases (Heart Disease) 06/2013

Drug/Important Bio-Agent (IBA)

33	Biomarkers (Surrogate Marker)IBA 03/2024 - 04/2012
30	apixabanIBA 03/2024 - 11/2012
26	Warfarin (Coumadin)FDA LinkGeneric 03/2024 - 11/2012
17	pro-brain natriuretic peptide (1-76)IBA 10/2023 - 04/2012
15	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2023 - 04/2012
11	AnticoagulantsIBA 01/2023 - 11/2012
10	CreatinineIBA 01/2023 - 03/2014
8	Troponin T (Troponin T1)IBA 10/2023 - 01/2014
8	Vitamin K FDA Link 01/2023 - 06/2015
8	Cystatin CIBA 01/2022 - 11/2012
8	Growth Differentiation Factor 15IBA 01/2022 - 11/2014
8	TroponinIBA 01/2020 - 11/2014
6	Troponin IIBA 01/2019 - 04/2012
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 12/2015
5	Dabigatran FDA Link 01/2020 - 03/2014
4	N(4)-oleylcytosine arabinosideIBA 10/2022 - 09/2015
4	Natriuretic PeptidesIBA 11/2021 - 06/2013
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 03/2024 - 11/2021
2	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 03/2024 - 01/2023
2	RivaroxabanIBA 01/2023 - 01/2022
2	Factor Xa (Coagulation Factor Xa)IBA 01/2023 - 01/2022
2	Trefoil Factor-3IBA 01/2022 - 12/2020
2	C-Reactive ProteinIBA 01/2017 - 12/2015
2	trans-crotonin (CTN)IBA 06/2016 - 05/2016
1	Angiopoietin-2IBA 01/2023
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2022
1	CalciumIBA 01/2022
1	CathepsinsIBA 01/2022
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2022
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2022
1	Fibroblast Growth Factor-23IBA 01/2022
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2022
1	darapladibIBA 01/2021
1	sortilinIBA 12/2020
1	Blood Proteins (Serum Proteins)IBA 12/2020
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 12/2020
1	OsteopontinIBA 12/2020
1	Cell Surface ReceptorsIBA 11/2020
1	Angiotensin-Converting Enzyme 2IBA 11/2020
1	DNA (Deoxyribonucleic Acid)IBA 11/2020
1	Thrombin FDA Link 01/2020
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	antineoplaston A10 (A 10)IBA 01/2020
1	Apolipoproteins B (ApoB)IBA 01/2018
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2018
1	ApolipoproteinsIBA 01/2018
1	Lipoproteins (Lipoprotein)IBA 01/2018
1	Indicators and Reagents (Reagents)IBA 08/2017
1	fibrin fragment D (D-dimer)IBA 01/2017
1	CytokinesIBA 01/2017
1	Trinitrotoluene (TNT)IBA 01/2014

Therapy/Procedure

21	Therapeutics 01/2023 - 04/2012
2	Percutaneous Coronary Intervention 01/2021 - 01/2019
2	Stents 01/2021 - 01/2020
1	Catheter Ablation 12/2023
1	Polypharmacy 01/2019
1	Drug Tapering 01/2016